About Cellino
Cellino is a company based in Cambridge (United States) founded in 2017 by Matthias Wagner, Marinna Madrid, and Nabiha Saklayen.. Cellino has raised $125 million across 6 funding rounds from investors including Khosla Ventures, Leaps by Bayer and 8VC. The company has 63 employees as of December 31, 2024. Cellino offers products and services including Nebula Platform and Autologous iPSC Therapy. Cellino operates in a competitive market with competitors including Sana Biotechnology, Semma Therapeutics, Adocia, UCB and Rezolute, among others.
- Headquarter Cambridge, United States
- Employees 63 as on 31 Dec, 2024
- Founders Matthias Wagner, Marinna Madrid, Nabiha Saklayen
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cellino Biotech, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$125 M (USD)
in 6 rounds
-
Latest Funding Round
$25 M (USD), Series A
Sep 18, 2024
-
Investors
Khosla Ventures
& 6 more
-
Employee Count
63
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cellino
Cellino offers a comprehensive portfolio of products and services, including Nebula Platform and Autologous iPSC Therapy. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-driven system for scalable biomanufacturing of personalized regenerative therapies
Treatments for degenerative diseases using patient-specific stem cells
Unlock access to complete
Funding Insights of Cellino
Cellino has successfully raised a total of $125M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $25 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series A — $25.0M
- First Round First Round
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Series A - Cellino | Valuation |
investors |
|
| Jan, 2022 | Amount | Series A - Cellino | Valuation | Leaps by Bayer , 8VC | |
| Feb, 2021 | Amount | Seed - Cellino | Valuation | Khosla Ventures , Engine Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cellino
Cellino has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Khosla Ventures, Leaps by Bayer and 8VC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in life sciences sector
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in technology, life sciences, and related sectors.
|
Founded Year | Domain | Location | |
|
Early-stage companies in science and technology are supported by Humboldt Fund.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cellino
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cellino
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cellino Comparisons
Competitors of Cellino
Cellino operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sana Biotechnology, Semma Therapeutics, Adocia, UCB and Rezolute, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for immunological and neurological disorders are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
|
| domain | founded_year | HQ Location |
Regenerative and gene therapeutics for heart failure are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cellino
Frequently Asked Questions about Cellino
When was Cellino founded?
Cellino was founded in 2017.
Where is Cellino located?
Cellino is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Who is the current CEO of Cellino?
Nabiha Saklayen is the current CEO of Cellino. They have also founded this company.
Is Cellino a funded company?
Cellino is a funded company, having raised a total of $125M across 6 funding rounds to date. The company's 1st funding round was a Seed of $16M, raised on Nov 02, 2017.
How many employees does Cellino have?
As of Dec 31, 2024, the latest employee count at Cellino is 63.
What does Cellino do?
Cellino was founded in 2017 in Cambridge, United States, and operates in the biotechnology sector focused on regenerative medicine. An AI-guided laser editing platform, single-cell laser processing, and robotics are utilized to generate autologous induced pluripotent stem cells. These therapies target diseases such as Parkinsons, diabetes, and heart disease, with operations centered on advancing cell-based treatments for clinical applications.
Who are the top competitors of Cellino?
Cellino's top competitors include Sana Biotechnology, Semma Therapeutics and Adocia.
What products or services does Cellino offer?
Cellino offers Nebula Platform and Autologous iPSC Therapy.
Who are Cellino's investors?
Cellino has 7 investors. Key investors include Khosla Ventures, Leaps by Bayer, 8VC, Humboldt Fund, and Felicis Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.